» Articles » PMID: 2868449

Erythromycin for Treatment and Prevention of Pertussis

Overview
Specialty Pediatrics
Date 1986 Jan 1
PMID 2868449
Citations 22
Authors
Affiliations
Soon will be listed here.
Citing Articles

Controlled Human Infection with Bordetella pertussis.

de Graaf H, Gbesemete D, Read R Curr Top Microbiol Immunol. 2023; 445:155-175.

PMID: 36964212 DOI: 10.1007/82_2022_260.


Optimization of sample preparation for culture-independent sequencing of .

Fong W, Rockett R, Timms V, Sintchenko V Microb Genom. 2020; 6(3).

PMID: 32108565 PMC: 7200065. DOI: 10.1099/mgen.0.000332.


SEVERE PERTUSSIS IN CHILDHOOD: UPDATE AND CONTROVERSY - SYSTEMATIC REVIEW.

Machado M, Passos S Rev Paul Pediatr. 2019; 37(3):351-362.

PMID: 31116241 PMC: 6868560. DOI: 10.1590/1984-0462/;2019;37;3;00006.


Isolation of High Level Macrolide Resistant Bordetella pertussis Without Transition Mutation at Domain V in Iran.

Mirzaei B, Bameri Z, Babaei R, Shahcheraghi F Jundishapur J Microbiol. 2015; 8(7):e18190.

PMID: 26396713 PMC: 4575774. DOI: 10.5812/jjm.8(5)2015.18190.


The use of macrolides in respiratory tract infections.

Pechere J Int J Antimicrob Agents. 1993; 3 Suppl 1:S53-61.

PMID: 18611579 PMC: 7135373. DOI: 10.1016/0924-8579(93)90035-4.